Skip to main content
. 2022 Oct 21;26:100537. doi: 10.1016/j.bbih.2022.100537

Table 1.

The outcomes and number of patients with affective disorders and healthy control along with the side of standardized mean difference (SMD) and the 95% confidence intervals with respect to zero SMD.

Outcome profiles n studies Side of 95% confidence intervals
Patient
Cases
Control
Cases
Total number of participants
<0 Overlap 0 and SMD <0 Overlap 0 and SMD >0 >0
TRP 106 48 48 8 2 5753 5288 11041
TRP/CAAs 18 7 11 0 0 423 607 1030
CAAs 14 1 6 4 3 330 503 833
KYN 67 19 30 15 3 4813 4356 9169
KYN/TRP 68 5 15 42 6 6007 5437 11444
(KYN+3HK+3HA + XA + QA + PA) 82 22 35 18 7 5392 4853 10245
KA/KYN 70 5 36 21 8 4987 4322 9309
KA 55 16 25 10 4 3905 3464 7369
3HK 26 4 10 11 1 1364 1244 2608

TRP: Tryptophan, KYN: Kynurenine, KA: Kynurenic acid, 3HK: 3-Hydroxykynurenine, 3HA: 3-Hydroxyanthranilic acid, XA: Xanthurenic acid, QA: Quinolinic acid, PA: Picolinic acid, AA: Anthranilic acid, SMD: Standardized Mean Difference, CAAs: Competing amino acids (Valine + Phenylalanine + Tyrosine + Leucine + Isoleucine).